VMD Medicines Update - November 2023 | British Equine Veterinary Association
We have updated our Privacy Policy. You can find out more here.

VMD Medicines Update - November 2023

News Medicines
20 Dec 2023 BEVA

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists changes to authorisations most relevant to equine vets.

Changes to authorisations most relevant to vets

The changes to authorisations most relevant to vets can be found below. Each product listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics sections have been revised/changed.

All entries can be found on the VMD’s Product Information Database here.

Changes to the SPC, labels and leaflets may change how the medicines should be used. There may be a delay between these changes being authorised to implementation on product literature. Unless you have been advised otherwise, the labelling instructions on the pack which is dispensed should be followed.

Equilis Te, Suspension for Injection, for Horses

MSD Animal Health UK Limited   GB   POM-V

Section 4.6: Addition of the adverse event hypersensitivity reaction with a very rare frequency

Proteq West Nile Suspension for Injection for Horses

Boehringer Ingelheim Vetmedica Gmbh    GB    POM-V

Section 4.6:  Addition of injection site abscess with a very rare frequency.

Section 4.9: For the administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material.

For more information, contact the VMD at postmaster@vmd.gov.uk